Topic Hub
17 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 17 of 17 clinical reviews.
Clinical guide to the drug interaction between resmetirom (Rezdiffra) and apixaban (Eliquis), covering CYP3A4 and P-gp mechanisms, severity grading, monitoring parameters, and dose-adjustment guidance for patients with MASH.
Read clinical reviewEvidence-based review of the resmetirom, clopidogrel drug interaction, including CYP2C19 mechanism, clinical severity, monitoring parameters, and dose-adjustment guidance.
Read clinical reviewClinical review of the drug interaction between Rezdiffra (resmetirom) and estradiol hormone replacement therapy, covering CYP metabolism, SHBG effects, VTE risk, and monitoring protocols.
Read clinical reviewCan you take Rezdiffra (resmetirom) with finasteride? A physician-reviewed guide covering CYP metabolism, pharmacodynamic considerations, monitoring protocols, and dose-adjustment advice.
Read clinical reviewCan you take Rezdiffra (resmetirom) with gabapentin? A physician-reviewed guide covering CYP metabolism, sedation risk, renal considerations, monitoring protocols, and dose-adjustment strategies.
Read clinical reviewClinical guide to the pharmacodynamic and absorption-related interaction between Rezdiffra (resmetirom) and levothyroxine, including mechanism, severity, monitoring, and dose-adjustment strategies.
Read clinical reviewCan you take Rezdiffra (resmetirom) with metformin? Review the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and dose-adjustment guidance for this common MASH-diabetes combination.
Read clinical reviewClinical guide to the drug interaction between Rezdiffra (resmetirom) and opioid analgesics including oxycodone, hydrocodone, and tramadol. Covers CYP3A4 induction, dose adjustments, monitoring, and patient counseling.
Read clinical reviewClinical guide to combining Rezdiffra (resmetirom) with proton pump inhibitors like omeprazole and pantoprazole. Covers absorption risk, CYP interactions, dose timing, and monitoring.
Read clinical reviewCan you take Rezdiffra (resmetirom) with rivaroxaban? Review the CYP3A4 and P-gp interaction mechanism, severity rating, monitoring labs, and dose-adjustment guidance backed by FDA labeling and primary literature.
Read clinical reviewClinical guide to the resmetirom-simvastatin drug interaction, including OATP1B1 inhibition mechanism, dose-adjustment strategies, rhabdomyolysis monitoring, and evidence from MAESTRO-NASH.
Read clinical reviewClinical review of the interaction between Rezdiffra (resmetirom) and SSRIs like sertraline and escitalopram, covering CYP metabolism, serotonin risk, monitoring, and dose adjustment.
Read clinical reviewCan you take Rezdiffra (resmetirom) with tadalafil? A physician-reviewed guide covering CYP metabolism, pharmacodynamic overlap, monitoring parameters, and dose-adjustment considerations.
Read clinical reviewCan you take Rezdiffra (resmetirom) with testosterone? Review the pharmacokinetic and pharmacodynamic interaction profile, monitoring protocols, and dose-adjustment guidance for this combination.
Read clinical reviewCan you take Rezdiffra (resmetirom) with trazodone? A clinician-reviewed guide to the CYP3A4 overlap, sedation risk, monitoring parameters, and dose-adjustment considerations for this drug combination.
Read clinical reviewClinical guide to the resmetirom-warfarin drug interaction. Covers CYP2C9 mechanism, INR monitoring protocols, dose adjustment strategies, and patient counseling for MASH patients on anticoagulation.
Read clinical reviewCan you take Rezdiffra (resmetirom) with zolpidem? A physician-reviewed guide covering CYP3A4 metabolism, CNS depression risk, dose adjustments, and monitoring for patients on both medications.
Read clinical review